J. Lipid Res. Please sign the JLR Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boberg, K. M.
Right arrow Articles by Bjorkhem, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boberg, K. M.
Right arrow Articles by Bjorkhem, I.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 31, 1083-1088, Copyright © 1990 by Lipid Research, Inc.


ARTICLES

Apparent lack of conversion of sitosterol into C24-bile acids in humans

KM Boberg, K Einarsson and I Bjorkhem
Institute of Clinical Biochemistry, University of Oslo, Rikshospitalet, Norway.

The metabolic fate of intravenously administered [4-14C]sitosterol was studied in two healthy subjects. In marked contrast to the results of a previous investigation with [22,23-3H]sitosterol, no detectable labeled C24-bile acid products appeared in bile. The first and rate-limiting step in the conversion of cholesterol into bile acids is catalyzed by the liver microsomal cholesterol 7 alpha-hydroxylase. When incubated with human liver microsomes, no detectable 7 alpha-hydroxylation of sitosterol could be demonstrated. This was the case also when using liver microsomes from two subjects treated with cholestyramine, in which case the rate of 7 alpha-hydroxylation of cholesterol was increased three- to sixfold. In order to bypass the rate-limiting step, the metabolic fate of 3H-labeled 7 alpha-hydroxysitosterol was studied in two volunteers. In this case there was a significant conversion into acid products in bile (18-32% excreted in bile during the first 17 h). Although part of the labeled products had chromatographic properties similar to those of cholic acid and chenodeoxycholic acid, further analysis showed that none of the products was identical to chenodeoxycholic acid and only traces at the most could be identical to cholic acid. The results suggest that healthy human subjects, in similarity with other mammalian species studied, have little or no capacity to convert sitosterol into the normal C24-bile acids.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Clin. Pathol.Home page
S Kidambi and S B Patel
Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis
J. Clin. Pathol., May 1, 2008; 61(5): 588 - 594.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. J. Clarenbach, M. Reber, D. Lutjohann, K. von Bergmann, and T. Sudhop
The lipid-lowering effect of ezetimibe in pure vegetarians
J. Lipid Res., December 1, 2006; 47(12): 2820 - 2824.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
T Sudhop, Y Sahin, B Lindenthal, C Hahn, C Luers, H K Berthold, and K von Bergmann
Comparison of the hepatic clearances of campesterol, sitosterol, and cholesterol in healthy subjects suggests that efflux transporters controlling intestinal sterol absorption also regulate biliary secretion
Gut, December 1, 2002; 51(6): 860 - 863.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Sudhop, D. Lutjohann, A. Kodal, M. Igel, D. L. Tribble, S. Shah, I. Perevozskaya, and K. von Bergmann
Inhibition of Intestinal Cholesterol Absorption by Ezetimibe in Humans
Circulation, October 8, 2002; 106(15): 1943 - 1948.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
B. Lindenthal, T. Sudhop, P. Schiedermaier, M. Agnan, T. Sauerbruch, and K. von Bergmann
Serum plant sterols and biliary cholesterol secretion in humans: studies with ursodeoxycholic acid
J. Lipid Res., July 1, 2002; 43(7): 1072 - 1077.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Plat, H. Brzezinka, D. Lutjohann, R. P. Mensink, and K. von Bergmann
Oxidized plant sterols in human serum and lipid infusions as measured by combined gas-liquid chromatography-mass spectrometry
J. Lipid Res., December 1, 2001; 42(12): 2030 - 2038.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Norlin, A. Toll, I. Björkhem, and K. Wikvall
24-Hydroxycholesterol is a substrate for hepatic cholesterol 7{alpha}-hydroxylase (CYP7A)
J. Lipid Res., October 1, 2000; 41(10): 1629 - 1639.
[Abstract] [Full Text]


Home page
J. Lipid Res.Home page
G. M. B. Berger, R. J. Pegoraro, S. B. Patel, P. Naidu, L. Rom, H. Hidaka, A. D. Marais, A. Jadhav, R. P. Naoumova, and G. R. Thompson
HMG-CoA reductase is not the site of the primary defect in phytosterolemia
J. Lipid Res., May 1, 1998; 39(5): 1046 - 1054.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.